08/17/2026 | Press release | Archived content
Document And Entity Information
|
Document And Entity Information - USD ($)
$ in Billions |
12 Months Ended
|
||
|
Jun. 30, 2026
|
Aug. 17, 2026
|
Dec. 31, 2025
|
|
|
Document Information [Line Items]
|
|||
|
Document Type
|
10-K
|
||
|
Document Annual Report
|
true
|
||
|
Document Period End Date
|
Jun. 30, 2026
|
||
|
Document Transition Report
|
false
|
||
|
Securities Act File Number
|
0-17272
|
||
|
Entity Registrant Name
|
BIO-TECHNE Corp
|
||
|
Entity Incorporation, State or Country Code
|
MN
|
||
|
Entity Tax Identification Number
|
41-1427402
|
||
|
Entity Address, Address Line One
|
614 McKinley Place N.E.
|
||
|
Entity Address, City or Town
|
Minneapolis
|
||
|
Entity Address, State or Province
|
MN
|
||
|
Entity Address, Postal Zip Code
|
55413
|
||
|
City Area Code
|
612
|
||
|
Local Phone Number
|
379-8854
|
||
|
Title of 12(b) Security
|
Common Stock, $0.01 par value
|
||
|
Trading Symbol
|
TECH
|
||
|
Security Exchange Name
|
NASDAQ
|
||
|
Entity Well-known Seasoned Issuer
|
Yes
|
||
|
Entity Voluntary Filers
|
No
|
||
|
Entity Current Reporting Status
|
Yes
|
||
|
Entity Interactive Data Current
|
Yes
|
||
|
Entity Filer Category
|
Large Accelerated Filer
|
||
|
Entity Small Business
|
false
|
||
|
Entity Emerging Growth Company
|
false
|
||
|
Entity Shell Company
|
false
|
||
|
ICFR Auditor Attestation Flag
|
true
|
||
|
Document Financial Statement Error Correction [Flag]
|
false
|
||
|
Entity Public Float
|
$ 9.1
|
||
|
Entity Common Stock, Shares Outstanding
|
156,818,238
|
||
|
Entity Central Index Key
|
0000842023
|
||
|
Current Fiscal Year End Date
|
--06-30
|
||
|
Document Fiscal Year Focus
|
2026
|
||
|
Document Fiscal Period Focus
|
FY
|
||
|
Amendment Flag
|
false
|
||
|
Auditor Name
|
KPMG LLP
|
||
|
Auditor Firm ID
|
185
|
||
|
Auditor Location
|
Minneapolis, Minnesota
|
||
|
Documents Incorporated by Reference [Text Block]
|
Portions of the Company's Proxy Statement for its 2026 Annual Meeting of Shareholders are incorporated by reference into Part III.
|